|

PM8002 Clinical Trials

4 actively recruiting trials

Pipeline

Phase 2: 1Phase 3: 2Phase 1/2: 1

Top Sponsors

  • Biotheus Inc.4

Indications

  • Cancer4
  • SCLC1
  • Malignant Neoplasm1
  • Neuroendocrine Neoplasm1
  • Triple Negative Breast Cancer (TNBC)1

Other4 trials

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Phase 2
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Phase 3
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Phase 1/2
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.